BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2545033)

  • 1. Crystallization of Sendai virus HN protein complexed with monoclonal antibody Fab fragments.
    Laver WG; Thompson SD; Murti KG; Portner A
    Virology; 1989 Jul; 171(1):291-3. PubMed ID: 2545033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of a biologically active soluble form of the hemagglutinin-neuraminidase protein of Sendai virus.
    Thompson SD; Laver WG; Murti KG; Portner A
    J Virol; 1988 Dec; 62(12):4653-60. PubMed ID: 2846877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of monoclonal antibodies against the hemagglutinin-neuraminidase and fusion protein on the release of Sendai virus from infected cells.
    Orvell C; Kristensson K
    Arch Virol; 1985; 86(1-2):1-15. PubMed ID: 2994598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing activity of the antibodies against two kinds of envelope glycoproteins of Sendai virus.
    Tozawa H; Komatsu H; Ohkata K; Nakajima T; Watanabe M; Tanaka Y; Arifuku M
    Arch Virol; 1986; 91(1-2):145-61. PubMed ID: 2428330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homooligomerization of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3 occurs before the acquisition of correct intramolecular disulfide bonds and mature immunoreactivity.
    Collins PL; Mottet G
    J Virol; 1991 May; 65(5):2362-71. PubMed ID: 1707981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of fluorescence photobleaching recovery to assess complex formation between the two envelope proteins of Sendai virus in membranes of fused human erythrocytes.
    Katzir Z; Gutman O; Henis YI
    Biochemistry; 1989 Jul; 28(15):6400-5. PubMed ID: 2551371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystallization and preliminary X-ray analysis of type B influenza virus neuraminidase complexed with antibody Fab fragments.
    Laver WG; Luo M; Bossart PJ; Babu YS; Smith C; Accavitti MA; Tulloch PA; Air GM
    Virology; 1988 Dec; 167(2):621-4. PubMed ID: 3201756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parainfluenza virus type 2 haemagglutinin-neuraminidase glycoprotein characterized with monoclonal antibodies.
    Rydbeck R; Löve A; Orvell C
    J Gen Virol; 1988 Apr; 69 ( Pt 4)():931-5. PubMed ID: 2451708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological relationships between mumps virus and parainfluenza viruses studied with monoclonal antibodies.
    Orvell C; Rydbeck R; Löve A
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1929-39. PubMed ID: 3018131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of functional sites on the hemagglutinin-neuraminidase glycoprotein of Sendai virus by sequence analysis of antigenic and temperature-sensitive mutants.
    Thompson SD; Portner A
    Virology; 1987 Sep; 160(1):1-8. PubMed ID: 2820122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane-bound antiviral antibodies as receptors for Sendai virions in receptor-depleted erythrocytes.
    Nussbaum O; Zakai N; Loyter A
    Virology; 1984 Oct; 138(2):185-97. PubMed ID: 6093364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystals of hemagglutinin-neuraminidase of parainfluenza virus contain triple-stranded helices.
    Murti KG; Takimoto T; Laver WG; Portner A
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1523-5. PubMed ID: 8381970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus type 1 and Sendai virus have high structure-function similarity with limited antigenic cross-reactivity.
    Gorman WL; Gill DS; Scroggs RA; Portner A
    Virology; 1990 Mar; 175(1):211-21. PubMed ID: 1689918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct functions of antigenic sites of the HN glycoprotein of Sendai virus.
    Portner A; Scroggs RA; Metzger DW
    Virology; 1987 May; 158(1):61-8. PubMed ID: 2437698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallization of biologically active hemagglutinin-neuraminidase glycoprotein dimers proteolytically cleaved from human parainfluenza virus type 1.
    Takimoto T; Laver WG; Murti KG; Portner A
    J Virol; 1992 Dec; 66(12):7597-600. PubMed ID: 1279210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T-lymphocyte reactivity with individual Sendai virus glycoproteins.
    Al-Ahdal MN; Nakamura I; Flanagan TD
    J Virol; 1985 Apr; 54(1):53-7. PubMed ID: 2983119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A recent field isolate of Sendai virus has a temperature-sensitive HN glycoprotein.
    Gorman WL; Portner A
    Virology; 1989 Feb; 168(2):413-6. PubMed ID: 2536989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activities of monoclonal antibodies to the hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus.
    Abenes GB; Kida H; Yanagawa R
    Nihon Juigaku Zasshi; 1986 Apr; 48(2):353-62. PubMed ID: 3712896
    [No Abstract]   [Full Text] [Related]  

  • 19. Drastic immunoreactivity changes between the immature and mature forms of the Sendai virus HN and F0 glycoproteins.
    Mottet G; Portner A; Roux L
    J Virol; 1986 Jul; 59(1):132-41. PubMed ID: 2423701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies specific for Sendai virus. I. Production and characterization of monoclonal antibodies.
    Fenner M; Binz H
    Scand J Immunol; 1986 Sep; 24(3):335-40. PubMed ID: 2428098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.